Literature DB >> 34043791

Rate and Predictors of 30-Day Readmission following Diabetic Ketoacidosis in Type 1 Diabetes Mellitus: A US Analysis.

Hafeez Shaka1, Maria Aguilera1, Maria Aucar2, Zain El-Amir2, Farah Wani3, Chukwudi Charles Muojieje4, Asim Kichloo2,3.   

Abstract

INTRODUCTION: This study aimed to describe rates and characteristics of non-elective 30-day readmission among adult patients with diabetes mellitus type 1 (T1DM) hospitalized for diabetic ketoacidosis (DKA) and also identify predictors of readmission.
METHODS: The study analyzed the 2018 Nationwide Readmission Database. DKA hospitalizations in patients with T1DM were classified using ICD-10-CM codes. We utilized Chi-square tests to compare baseline characteristics between readmissions and index hospitalizations. Multivariable cox regression was employed to identify independent predictors of readmission. Following this, we developed a 30-day readmission risk scoring system based on independent predictors.
RESULTS: The 30-day all-cause readmission rate for DKA was 19.4%. A majority of patients (64.8%) had DKA as the principal diagnosis on readmission. Readmitted patients had a significantly higher mean age (35.3 vs. 34.9 years, p=0.018) and a higher proportion of females (52.8 vs. 49.6%,p<0.001) compared to the index admission. Readmission following DKA was associated with higher odds of inpatient mortality (0.69 vs. 0.24%, OR: 2.84, 95% CI: 1.99 - 4.06, p<0.001). Independent predictors of 30-day all-cause readmission included female sex, index hospitalizations with Charlson Comorbidity Index (CCI) score of 3 or greater, and being discharged against medical advice (AMA).
CONCLUSION: The readmission rate for DKA in T1DM patients is high, and most patients have DKA as the principal diagnosis on readmission. A CCI equal to or greater than 3, hypertension, female sex, and being discharged AMA were significant predictors of readmission.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Diabetes Mellitus Type 1; Diabetic Ketoacidosis; Readmission

Year:  2021        PMID: 34043791     DOI: 10.1210/clinem/dgab372

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

1.  Comorbidities in Recent-Onset Adult Type 1 Diabetes: A Comparison of German Cohorts.

Authors:  Oana P Zaharia; Stefanie Lanzinger; Joachim Rosenbauer; Wolfram Karges; Karsten Müssig; Sebastian M Meyhöfer; Volker Burkart; Michael Hummel; Dirk Raddatz; Michael Roden; Julia Szendroedi; Reinhard W Holl
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-03       Impact factor: 6.055

2.  Management of hospitalized patients with mild to moderate diabetic ketoacidosis using a continuous insulin infusion protocol on a medical surgical ward and observation level of care: A retrospective cohort study.

Authors:  Michael S Yoo; Abraham Daniels; Rene A Maslow; John A Gomez; Nannette L Meyers; Pamela S Bohrer; Siamack Nemazie; Christina E Sanford; Emily A Peterson; Kendal L Hamann; Darcy E Walsh; Alison M O'Herlihy; Vivek Kumra
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

3.  A Revised Comorbidity Model for Administrative Databases Using Clinical Classifications Software Refined Variables.

Authors:  Hafeez Shaka; Ehizogie Edigin
Journal:  Cureus       Date:  2021-12-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.